Home Newsfeeds Piper Sandler Maintains Overweight on Bank of America, Lowers Price Target to $47

Piper Sandler Maintains Overweight on Bank of America, Lowers Price Target to $47

Piper Sandler analyst Jeffery Harte maintains Bank of America (NYSE:BAC) with a Overweight and lowers the price target from $51 to $47.

byBenzinga Newsdesk

July 1, 2022

1 minute read

Piper Sandler analyst Jeffery Harte maintains Bank of America (NYSE:BAC) with a Overweight and lowers the price target from $51 to $47.

News

Arbe Releases Its Production Radar Processor, Delivering The Strongest Dedicated Automotive Radar Processing Solution On The Market

By Benzinga Newsdesk

November 28, 10:11 AM

Arbe's Radar Processor is Used for OEM Development Projects and Tier-1 B-Sample Radars TEL AVIV, Israel, November 28, 2023 - Arbe RoboticsLtd. (NASDAQ:ARBE), a global leader in Perception

ARBE

Goldman Sachs Boosts Price Target On JinkoSolar Following Q2 Earnings, Also Check Out Other Major PT Changes Here

By Lisa Levin

August 29, 8:24 AM

Oppenheimer raised the price target on S&P Global Inc. (NYSE: SPGI) from $404 to $419. Oppenheimer analyst Owen Lau maintained an Outperform rating on the stock. S&P Global shares fell 1% to $360.46 in pre-market trading.

CHWY

Wells Fargo Downgrades Stanley Black & Decker to Equal-Weight, Announces $105 Price Target

By Benzinga Newsdesk

August 1, 5:24 AM

Wells Fargo analyst Joseph O'Dea downgrades Stanley Black & Decker (NYSE:SWK) from Overweight to Equal-Weight and announces $105 price target.

SWK

Verastem Presents Avutometinib And Defactinib Combination Program Updates At The 5th Annual RAS-Targeted Drug Development Summit

By Benzinga Newsdesk

September 28, 2:16 PM

Preclinical and Clinical Presentations Include Update on FRAME Study Low-Grade Serous Ovarian Cancer Efficacy DataVerastem Oncology, (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for

VSTM

Piper Sandler Maintains Overweight on Bank of America, Lowers Price Target to $47

Related Posts

Arbe Releases Its Production Radar Processor, Delivering The Strongest Dedicated Automotive Radar Processing Solution On The Market

Goldman Sachs Boosts Price Target On JinkoSolar Following Q2 Earnings, Also Check Out Other Major PT Changes Here

Wells Fargo Downgrades Stanley Black & Decker to Equal-Weight, Announces $105 Price Target

Verastem Presents Avutometinib And Defactinib Combination Program Updates At The 5th Annual RAS-Targeted Drug Development Summit